Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Receivables (2020 - 2025)

Historic Receivables for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to $32.6 million.

  • Ginkgo Bioworks Holdings' Receivables rose 355.11% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 355.11%. This contributed to the annual value of $33.2 million for FY2024, which is 2164.58% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Receivables stood at $32.6 million, which was up 355.11% from $33.1 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Receivables ranged from a high of $178.1 million in Q2 2022 and a low of $24.2 million during Q1 2024
  • In the last 5 years, Ginkgo Bioworks Holdings' Receivables had a median value of $44.7 million in 2021 and averaged $68.9 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Receivables surged by 71551.46% in 2021 and then tumbled by 7094.66% in 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Receivables (Quarter) stood at $136.1 million in 2021, then tumbled by 40.57% to $80.9 million in 2022, then tumbled by 66.31% to $27.3 million in 2023, then rose by 21.65% to $33.2 million in 2024, then decreased by 1.59% to $32.6 million in 2025.
  • Its Receivables stands at $32.6 million for Q3 2025, versus $33.1 million for Q2 2025 and $26.3 million for Q1 2025.